![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Acknowledgements
ISL is supported by grant 1R01CA233945 from the National Cancer Institute, the Dwoskin, and Anthony Rizzo Families Foundations and Jaime Erin Follicular Lymphoma Research Consortium. JPA is a K12 Scholar supported by the National Cancer Institute of the National Institutes of Health under Award Number K12CA226330. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Author contributions
ISL conceptualized and designed the study, analyzed the data and wrote the manuscript, IMR analyzed the data and wrote the manuscript, JDR was involved in the treatment of these patients, and JPA collected and analyzed the data, and wrote the manuscript; all authors read and approved the final version of the manuscript.
Disclosure statement
I.S.L. has served on advisory boards from Seattle Genetics, Janssen Scientific and Verastem.
JDR has been employed from Merck, Mologen AG, Kite Pharma, and Synergies, has served on advisory boards from Merck, Kite Pharma, Pharmacyclics, and Seattle Genetics.
J.P.A. has received honoraria from OncLive and Oncinfo, and immediate family member has served on advisory boards from Puma Biotechnology, Inovio Pharmaceuticals, Agios Pharmaceuticals, Forma Therapeutics and Foundation Medicine.